351 related articles for article (PubMed ID: 11583591)
1. Study of the interaction of the medium chain mu 2 subunit of the clathrin-associated adapter protein complex 2 with cytotoxic T-lymphocyte antigen 4 and CD28.
Follows ER; McPheat JC; Minshull C; Moore NC; Pauptit RA; Rowsell S; Stacey CL; Stanway JJ; Taylor IW; Abbott WM
Biochem J; 2001 Oct; 359(Pt 2):427-34. PubMed ID: 11583591
[TBL] [Abstract][Full Text] [Related]
2. Interaction of CTLA-4 with AP50, a clathrin-coated pit adaptor protein.
Zhang Y; Allison JP
Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9273-8. PubMed ID: 9256472
[TBL] [Abstract][Full Text] [Related]
3. Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression.
Chuang E; Alegre ML; Duckett CS; Noel PJ; Vander Heiden MG; Thompson CB
J Immunol; 1997 Jul; 159(1):144-51. PubMed ID: 9200449
[TBL] [Abstract][Full Text] [Related]
4. Interaction of the cytoplasmic tail of CTLA-4 (CD152) with a clathrin-associated protein is negatively regulated by tyrosine phosphorylation.
Bradshaw JD; Lu P; Leytze G; Rodgers J; Schieven GL; Bennett KL; Linsley PS; Kurtz SE
Biochemistry; 1997 Dec; 36(50):15975-82. PubMed ID: 9398332
[TBL] [Abstract][Full Text] [Related]
5. Cytolytic T lymphocyte-associated antigen-4 and the TCR zeta/CD3 complex, but not CD28, interact with clathrin adaptor complexes AP-1 and AP-2.
Schneider H; Martin M; Agarraberes FA; Yin L; Rapoport I; Kirchhausen T; Rudd CE
J Immunol; 1999 Aug; 163(4):1868-79. PubMed ID: 10438921
[TBL] [Abstract][Full Text] [Related]
6. Janus kinase 2 is associated with a box 1-like motif and phosphorylates a critical tyrosine residue in the cytoplasmic region of cytotoxic T lymphocyte associated molecule-4.
Chikuma S; Murakami M; Tanaka K; Uede T
J Cell Biochem; 2000 May; 78(2):241-50. PubMed ID: 10842319
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2.
Shiratori T; Miyatake S; Ohno H; Nakaseko C; Isono K; Bonifacino JS; Saito T
Immunity; 1997 May; 6(5):583-9. PubMed ID: 9175836
[TBL] [Abstract][Full Text] [Related]
8. Chimeric co-stimulatory molecules that selectively act through CD28 or CTLA-4 on human T cells.
Lazetic S; Leong SR; Chang JC; Ong R; Dawes G; Punnonen J
J Biol Chem; 2002 Oct; 277(41):38660-8. PubMed ID: 12167647
[TBL] [Abstract][Full Text] [Related]
9. The 50 kDa protein subunit of assembly polypeptide (AP) AP-2 adaptor from clathrin-coated vesicles is phosphorylated on threonine-156 by AP-1 and a soluble AP50 kinase which co-purifies with the assembly polypeptides.
Pauloin A; Thurieau C
Biochem J; 1993 Dec; 296 ( Pt 2)(Pt 2):409-15. PubMed ID: 8257432
[TBL] [Abstract][Full Text] [Related]
10. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.
Peach RJ; Bajorath J; Brady W; Leytze G; Greene J; Naemura J; Linsley PS
J Exp Med; 1994 Dec; 180(6):2049-58. PubMed ID: 7964482
[TBL] [Abstract][Full Text] [Related]
11. The B cell coreceptor CD22 associates with AP50, a clathrin-coated pit adapter protein, via tyrosine-dependent interaction.
John B; Herrin BR; Raman C; Wang YN; Bobbitt KR; Brody BA; Justement LB
J Immunol; 2003 Apr; 170(7):3534-43. PubMed ID: 12646615
[TBL] [Abstract][Full Text] [Related]
12. Short cytoplasmic SDYMNM segment of CD28 is sufficient to convert CTLA-4 to a positive signaling receptor.
Yin L; Schneider H; Rudd CE
J Leukoc Biol; 2003 Jan; 73(1):178-82. PubMed ID: 12525576
[TBL] [Abstract][Full Text] [Related]
13. Binding stoichiometry of the cytotoxic T lymphocyte-associated molecule-4 (CTLA-4). A disulfide-linked homodimer binds two CD86 molecules.
Linsley PS; Nadler SG; Bajorath J; Peach R; Leung HT; Rogers J; Bradshaw J; Stebbins M; Leytze G; Brady W
J Biol Chem; 1995 Jun; 270(25):15417-24. PubMed ID: 7541042
[TBL] [Abstract][Full Text] [Related]
14. ARH is a modular adaptor protein that interacts with the LDL receptor, clathrin, and AP-2.
He G; Gupta S; Yi M; Michaely P; Hobbs HH; Cohen JC
J Biol Chem; 2002 Nov; 277(46):44044-9. PubMed ID: 12221107
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex.
Schwartz JC; Zhang X; Fedorov AA; Nathenson SG; Almo SC
Nature; 2001 Mar; 410(6828):604-8. PubMed ID: 11279501
[TBL] [Abstract][Full Text] [Related]
16. Structure of murine CTLA-4 and its role in modulating T cell responsiveness.
Ostrov DA; Shi W; Schwartz JC; Almo SC; Nathenson SG
Science; 2000 Oct; 290(5492):816-9. PubMed ID: 11052947
[TBL] [Abstract][Full Text] [Related]
17. Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28.
Metzler WJ; Bajorath J; Fenderson W; Shaw SY; Constantine KL; Naemura J; Leytze G; Peach RJ; Lavoie TB; Mueller L; Linsley PS
Nat Struct Biol; 1997 Jul; 4(7):527-31. PubMed ID: 9228944
[TBL] [Abstract][Full Text] [Related]
18. Stabilization of clathrin coats by the core of the clathrin-associated protein complex AP-2.
Matsui W; Kirchhausen T
Biochemistry; 1990 Dec; 29(48):10791-8. PubMed ID: 2125494
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the interaction between tyrosine-based motifs and the medium chain subunit of the AP-2 adaptor complex by specific tyrphostins.
Crump CM; Williams JL; Stephens DJ; Banting G
J Biol Chem; 1998 Oct; 273(43):28073-7. PubMed ID: 9774424
[TBL] [Abstract][Full Text] [Related]
20. Differential recognition by CD28 of its cognate counter receptors CD80 (B7.1) and B70 (B7.2): analysis by site directed mutagenesis.
Truneh A; Reddy M; Ryan P; Lyn SD; Eichman C; Couez D; Hurle MR; Sekaly RP; Olive D; Sweet R
Mol Immunol; 1996 Feb; 33(3):321-34. PubMed ID: 8649453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
